Severe cutaneous adverse reactions induced by targeted anticancer therapies and immunotherapies-Reference-Cited by-同舟云学术

Severe cutaneous adverse reactions induced by targeted anticancer therapies and immunotherapies

Published:2018-05 Issue: Volume:Volume 10 Page:1259-1273
ISSN:1179-1322
Container-title:Cancer Management and Research
language:en
Short-container-title:CMAR

Author:

Chen Chun-Bing^ORCID,Wu Ming-Ying^ORCID,Ng Chau Yee^ORCID,Lu Chun-Wei^ORCID,Wu Jennifer^ORCID,Kao Pei-Han,Yang Chan-Keng,Peng Meng-Ting,Huang Chen-Yang,Chang Wen-Cheng^ORCID,Hui Rosaline Chung-Yee^ORCID,Yang Chih-Hsun,Yang Shun-Fa^ORCID,Chung Wen-Hung,Su Shih-Chi

Publisher

Informa UK Limited

Subject

Oncology

Cited by 121 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Untargeted metabolomics analysis reveals the potential mechanism of imatinib-induced skin rash in patients with gastrointestinal stromal tumor;International Immunopharmacology;2024-10

2. The spectrum of cutaneous toxicities related to novel genitourinary cancer therapies;Critical Reviews in Oncology/Hematology;2024-08

3. Consensus of the Taiwanese dermatological association and Taiwan Lung Cancer Society on the prevention and management of tyrosine kinase inhibitor-related skin toxicities in patients with non-small cell lung cancer: An updated version incorporating Taiwanese treatment experience;Journal of the Formosan Medical Association;2024-08

4. Optimal Practices in the Delivery of Aesthetic Medical Care to Patients on Immunosuppressants and Immunomodulators: A Systematic Review of the Literature;Aesthetic Surgery Journal;2024-07-05

5. Furmonertinib-Induced Toxic Epidermal Necrolysis in a Patient with Advanced Lung Adenocarcinoma;Dermatitis®;2024-07-04